HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Combination use of lentinan with X-ray therapy in a mouse experimental tumor system (Part I). Basic studies].

Abstract
Apparent reduction of leukocyte counts was observed in mice irradiated with 1,500 approximately 3,000 rads of X-ray on the left hind leg. This reduction of leukocyte counts was completely protected by the pre-treatment with lentinan before X-ray irradiation. Suppressive effect of X-ray on the antitumor function of lentinan seems to be weak. When treatment with X-ray irradiation and lentinan was applied for mice bearing solid type sarcoma 180, additive effect was obtained by the combination of lentinan before or after X-ray irradiation.
AuthorsT Shiio, Y Tsuchiya, K Ohishi, T Yoshihama
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 15 Issue 2 Pg. 313-7 (Feb 1988) ISSN: 0385-0684 [Print] Japan
PMID3341791 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Polysaccharides
  • Lentinan
Topics
  • Animals
  • Combined Modality Therapy
  • Female
  • Lentinan (administration & dosage)
  • Leukopenia (prevention & control)
  • Mice
  • Mice, Inbred ICR
  • Polysaccharides (administration & dosage)
  • Radiotherapy Dosage
  • Remission Induction
  • Sarcoma 180 (pathology, radiotherapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: